111 related articles for article (PubMed ID: 8898164)
1. Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.
Pertschuk LP; Masood S; Simone J; Feldman JG; Fruchter RG; Axiotis CA; Greene GL
Gynecol Oncol; 1996 Oct; 63(1):28-33. PubMed ID: 8898164
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.
Reiner A; Neumeister B; Spona J; Reiner G; Schemper M; Jakesz R
Cancer Res; 1990 Nov; 50(21):7057-61. PubMed ID: 2208173
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H
Gynecol Oncol; 1998 Jun; 69(3):220-5. PubMed ID: 9648591
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma.
Suthipintawong C; Wejaranayang C; Vipupinyo C
J Med Assoc Thai; 2008 Dec; 91(12):1779-84. PubMed ID: 19133508
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation.
Brustein S; Fruchter R; Greene GL; Pertschuk LP
Mod Pathol; 1989 Sep; 2(5):449-55. PubMed ID: 2682614
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.
Høgdall EV; Christensen L; Høgdall CK; Blaakaer J; Gayther S; Jacobs IJ; Christensen IJ; Kjaer SK
Oncol Rep; 2007 Nov; 18(5):1051-9. PubMed ID: 17914554
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical evaluation of estrogen and progesterone receptors in paraffin-embedded, formalin-fixed endometrial tissues: comparison with enzyme immunoassay and immunohistochemical analysis of frozen tissue.
Ravn V; Havsteen H; Thorpe SM
Mod Pathol; 1998 Aug; 11(8):709-15. PubMed ID: 9720497
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of hormone receptors in breast carcinomas (ER-ICA, PgR-ICA): prognostic usefulness and comparison with the biochemical radioactive-ligand-binding assay (DCC).
Beck T; Weikel W; Brumm C; Wilkens C; Pollow K; Knapstein PG
Gynecol Oncol; 1994 May; 53(2):220-7. PubMed ID: 8188083
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer.
Jongen V; Briët J; de Jong R; ten Hoor K; Boezen M; van der Zee A; Nijman H; Hollema H
Gynecol Oncol; 2009 Mar; 112(3):537-42. PubMed ID: 19108875
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of HER2 and progesterone receptor expression in endometrial carcinoma with positive peritoneal washing.
Benevolo M; Vocaturo A; Novelli F; Mariani L; Vocaturo G; Cianciulli AM; Marandino F; Perrone-Donnorso R; Giannarelli D; Natali PG; Mottolese M
Anticancer Res; 2007; 27(4C):2839-44. PubMed ID: 17695457
[TBL] [Abstract][Full Text] [Related]
12. A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma.
Oreskovic S; Babic D; Kalafatic D; Barisic D; Beketic-Oreskovic L
Gynecol Oncol; 2004 Apr; 93(1):34-40. PubMed ID: 15047211
[TBL] [Abstract][Full Text] [Related]
13. [The prognostic significance of progesterone receptor level in endometrial cancer].
Nyholm HC; Christensen IJ; Nielsen AL
Ugeskr Laeger; 1997 Jan; 159(5):601-4. PubMed ID: 9045451
[TBL] [Abstract][Full Text] [Related]
14. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
15. Expression of cyclooxygenase-2 (COX-2), receptors for estrogen (ER), and progesterone (PR), p53, ki67, and neu protein in endometrial cancer.
Ferrandina G; Ranelletti FO; Gallotta V; Martinelli E; Zannoni GF; Gessi M; Scambia G
Gynecol Oncol; 2005 Sep; 98(3):383-9. PubMed ID: 15979129
[TBL] [Abstract][Full Text] [Related]
16. Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival.
Pertschuk LP; Kim DS; Nayer K; Feldman JG; Eisenberg KB; Carter AC; Rong ZT; Thelmo WL; Fleisher J; Greene GL
Cancer; 1990 Oct; 66(8):1663-70. PubMed ID: 2208020
[TBL] [Abstract][Full Text] [Related]
17. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.
Rakha EA; El-Sayed ME; Green AR; Paish EC; Powe DG; Gee J; Nicholson RI; Lee AH; Robertson JF; Ellis IO
J Clin Oncol; 2007 Oct; 25(30):4772-8. PubMed ID: 17876012
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endometrial cancer.
Tecimer C; Doering DL; Goldsmith LJ; Meyer JS; Abdulhay G; Wittliff JL
Gynecol Oncol; 2001 Jan; 80(1):48-55. PubMed ID: 11136569
[TBL] [Abstract][Full Text] [Related]
20. Progesterone receptor levels independently predict survival in endometrial adenocarcinoma.
Nyholm HC; Christensen IJ; Nielsen AL
Gynecol Oncol; 1995 Dec; 59(3):347-51. PubMed ID: 8522253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]